Heart failure trials in China

In China 145 Also abroad 1265

145 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Baotou, Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Guangzhou, Hangzhou, Harbin, Hengyang, Heze, Hohhot, Jinan, Jining, Lanzhou, Liaocheng, Linhai, Nanchang, Nanchong, Nanjing, Ningbo, Pingxiang, Quzhou, Sanya, Shanghai, Shenyang, Shenzhen, Ürümqi, Wuhan, Xi'an, Xianyang, Xuzhou, Yangzhou, Zhangjiakou, Zunyi
Age
18 years to 130 years
People
3,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00
No phaseTaking people
A Village Doctor-led Telehealth Supported Trial of Heart Failure Prevention in AF Patients: MIRACLE-AF 2 (Heart Failure Prevention)
Where
Xuzhou, Yancheng, Yangzhou
Age
65 years to 80 years
People
1,356
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07492498
No phaseTaking people
A Village Doctor-led Telehealth Supported Improvement of Outcomes of AF Patients With Heart Failure Due to Reduced or Preserved Ejection Fraction: The MIRACLE-AF 2 Heart Failure Management Trial (MIRACLE AF-HF)
Where
Xuzhou, Yancheng, Yangzhou
Age
65 years to 80 years
People
942
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07492524
Phase 3Taking people
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Where
Baoding, Baotou, Beijing, Bozhou, Changchun, Changde, Changsha, Chengdu, Chifeng, Daqing, Foshan, Guangzhou, Haikou, Hefei, Heze, Huaian, Huizhou, Jiangmen, Jinan, Jining, Lanzhou, Linhai, Lishui, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Panjin, Pingxiang, Qingzhou, Sanya, Shanghai, Shantou, Shaoguan, Shaoxing, Shenyang, Shenzhen, Siping, Suining, Suzhou, Taian, Tianjin, Ürümqi, Wanzhou, Weifang, Wenzhou, Wuhan, Wuxi, Xi'an, Xiangtan, Xuzhou, Yancheng, Yangzhou, Yueyang, Yuncheng, Zhangjiakou, Zhengzhou, Zibo, Zigong, Zunyi
Age
18 years and over
People
6,950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00
No phaseNot yet taking people in China
Real-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure
Where
Jinan, Tianjin
Age
40 years to 80 years
People
200
Run by
China Academy of Chinese Medical Sciences
See details and how to joinNCT07841275
Phase 2Taking people
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
Where
Beijing
Age
18 years and over
People
153
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07318103
No phaseNot yet taking people in China
Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
Where
Beijing
Age
18 years and over
People
5,000
Run by
Boehringer Ingelheim
See details and how to joinNCT07044700
Phase 2/3Taking people
Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction
Where
Beijing
Age
18 years and over
People
208
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07820410
No phaseTaking people
Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
Where
Beijing
Age
18 years and over
People
400
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07414225
No phaseTaking people
Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure
Where
Nanchang
Age
18 years to 80 years
People
100
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07814612
Phase 3Taking people
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Where
Changsha, Chengdu, Guangzhou, Hangzhou, Jinan, Shanghai, Taiyuan, Tianjin, Xian City
Age
18 years and over
People
1,500 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06024746
No phaseNot yet taking people in China
Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
Where
Guangzhou, Jinan, Tianjin, Zhengzhou
Age
40 years to 80 years
People
100
Run by
China Academy of Chinese Medical Sciences
See details and how to joinNCT07803471
Phase 1/2Taking people
A Study of Metformin to Improve Cardiac Function After LVAD Implantation
Where
Ha’erbin, Hangzhou, Huai'an, Nanjing, Zhengzhou
Age
18 years to 75 years
People
108
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07666698
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Baotou, Changchun, Changsha, Changzhou, Guangzhou, Harbin, Jinan, Jining, Nanjing, Shanghai, Shenyang, Shijiazhuang, Siping, Suzhou, Tianjin, Wuhan, Xi'an, Xuzhou
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseNot yet taking people in China
A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart Failure
Where
Wuhan
Age
18 years to 75 years
People
64
Run by
Shenzhen Core Medical Technology CO.,LTD.
See details and how to joinNCT07757451
No phaseTaking people
Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
Where
Nanjing
Age
18 years and over
People
100
Run by
The Second Hospital of Nanjing Medical University
See details and how to joinNCT07621367
No phaseNot yet taking people in China
Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
Where
Taizhou
Age
18 years to 65 years
People
20
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07740044
Phase 3Taking people
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Where
Beijing
Age
2 years to 11 years
People
9 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06597006
No phaseTaking people
AI-Optimized Single-Feature Recognition Model for Heart Failure
Where
Hangzhou
Age
18 years and over
People
50
Run by
Vivalink
See details and how to joinNCT07667452
No phaseTaking people
Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure
Where
Beijing, Hefei
Age
18 years and over
People
6
Run by
Shenzhen Core Medical Technology CO.,LTD.
See details and how to joinNCT07704424
Phase 1/2Taking people
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
Where
Hangzhou
Age
18 years to 75 years
People
43
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06902896
No phaseTaking people
Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)
Where
Shanghai
Age
18 years to 90 years
People
1,740
Run by
Ruijin Hospital Luwan Branch
See details and how to joinNCT07701876
Phase 1/2Not yet taking people in China
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
Where
Xi’an
Age
60 years and over
People
162
Run by
The First Affiliated Hospital of Air Force Medical University
See details and how to joinNCT07687212
Phase 1Taking people
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Where
Hangzhou
Age
18 years to 75 years
People
5
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07516288
No phaseTaking people
FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart Failure
Where
Beijing
Age
18 years and over
People
122
Run by
Beijing Chao Yang Hospital
See details and how to joinNCT07657650